top of page

Scientific studies on mRNA

Administration of a Second Dose of the Moderna COVID-19 Vaccine After an Immediate Hypersensitivity Reaction With the First Dose, Two Case Reports

Allergic

Administration of the Second Dose of mRNA COVID-19 Vaccine to a Woman With Immediate Reaction to the First Dose

Allergic

Allergenic components of the mRNA-1273 vaccine for COVID-19, Possible involvement of polyethylene glycol and IgG-mediated complement activation

Allergic

Allergic Reactions After COVID-19 Vaccination-Putting Risk Into Perspective

Allergic

Allergic reactions and adverse events associated with administration of mRNA-based vaccines. A health-care system experience

Allergic

Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines

Allergic

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine - United States, December 21, 2020-January 10, 2021

Allergic

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020

Allergic

Allergic reactions to the first COVID-19 vaccine, A potential role of polyethylene glycol

Allergic

Allergy to Polyethilenglicole of Anti-SARS CoV2 Vaccine Recipient, A Case Report of Young Adult Recipient and the Management of Future Exposure to SARS-CoV2

Allergic

An academic hospital experience screening mRNA COVID-19 vaccine risk using patient allergy history

Allergic

Anaphylactic reactions after COVID-19 vaccination in Germany

Allergic

Anaphylactic reactions to mRNA COVID-19 vaccines, A call for further study

Allergic

Anaphylaxis after Moderna COVID-19 vaccine

Allergic

Anaphylaxis After the Covid-19 Vaccine in a Patient With Cholinergic Urticaria

Allergic

Anaphylaxis associated with the mRNA COVID-19 vaccines, Approach to allergy investigation

Allergic

Anaphylaxis to Pfizer BioNTech mRNA COVID-19 Vaccine in a Patient With Clinically Confirmed PEG Allergy

Allergic

Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health System

Allergic

Biphasic anaphylaxis after exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine

Allergic

Biphasic anaphylaxis after first dose of messenger RNA coronavirus disease 2019 vaccine with positive polysorbate 80 skin testing result

Allergic
bottom of page